免疫球蛋白类转录5极化M2类瘤相关的巨细胞,用于非小细胞肺癌的免疫抑制
Huijun Xu1,2, Xuebing Fu3, Shuyun Wang4
1Jinan Central Hospital, Shandong University, Jinan, Shandong, China.
International journal of cancer
|February 5, 2025
概括
免疫球蛋白样转录5 (ILT5) 在非小细胞肺癌 (NSCLC) 中促进免疫抑制性瘤微环境. 在与瘤相关的巨细胞中准ILT5可能会改善NSCLC患者的免疫治疗疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 免疫检查点抑制剂 (ICI) 已经彻底改变了非小细胞肺癌 (NSCLC) 治疗.
- 对ICI的有限反应率通常是由于免疫抑制性瘤微环境 (TME).
- 确定克服TME介导免疫抑制的新目标对于提高ICI疗效至关重要.
研究的目的:
- 研究NSCLC中免疫球蛋白样转录5 (ILT5) 的表达和功能.
- 确定ILT5在塑造瘤微环境中的作用及其对患者生存的影响.
- 评估ILT5作为一种潜在的治疗标和NSCLC的预后生物标志物.
主要方法:
- 在NSCLC组织中分析ILT5表达及其与患者存活率的相关性.
- 功能性研究以阐明ILT5在巨细胞极化和T细胞透中的作用.
- 在体内实验中使用ILT5淘汰模型来评估瘤生长抑制.
主要成果:
- 在NSCLC中,ILT5在瘤相关巨细胞 (TAM) 中高度表达,并与患者的生存率差相关.
- ILT5促进TAMs的M2样两极化,导致T细胞密度下降和FOXP3+T细胞积累增加,产生免疫抑制的TME.
- 结合ILT5表达和M2型TAM密度作为一个比单独ILT5更强大的预后生物标志物.
- ILT5淘汰抑制了TAM重编程,减少了免疫抑制T细胞子集,并在体内抑制了瘤生长.
结论:
- ILT5通过调节TAM和T细胞种群,在NSCLC中促进免疫抑制性TME发挥着重要作用.
- ILT5代表了一种有前途的新型免疫治疗标,用于提高ICI在NSCLC中的疗效.
- ILT5,特别是与M2型TAM密度结合,是NSCLC患者的有价值的预后生物标志物.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.4K
10:43Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
28.5K
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
